Back
ESC Premium Access

Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Session: Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF
Topic: Pharmacotherapy
Speaker: Professor L. Tumasyan (Yerevan, AM)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Professor Liana Tumasyan

Institute of Cardiology of Yerevan, Yerevan (Armenia)
0 follower

9 more presentations in this session

Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis

Speaker: Associate Professor H. Fukuta (Nagoya, JP)

Access
Abstract
Like
Thumbnail

The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Speaker: Doctor C. Wei-Ting (Tainan, TW)

Access
Abstract
Slides
Like
Thumbnail

Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study

Speaker: Doctor K. Tsukamoto (Tokyo, JP)

Access
Abstract
Like
Thumbnail

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Speaker: Professor J. Spinar (Brno, CZ)

Access
Abstract
Slides
Like
Thumbnail

Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

Speaker: Doctor E. Santas Olmeda (Valencia, ES)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

Speakers: Professor L. Tumasyan, Associate Professor H. Fukuta, Doctor C. Wei-Ting, Doctor K. Tsukamoto, Professor J. Spinar...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources